Affiliation
Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Ireland. k.ismail@ucc.ieIssue Date
2011-03MeSH
AspirinFemale
Hemostasis
Heparin, Low-Molecular-Weight
Humans
Hypertension, Pregnancy-Induced
Placental Circulation
Placentation
Pre-Eclampsia
Pregnancy
Thrombophilia
Metadata
Show full item recordCitation
Hemostasis in pre-eclampsia. 2011, 37 (2):111-7 Semin. Thromb. Hemost.Journal
Seminars in thrombosis and hemostasisDOI
10.1055/s-0030-1270336PubMed ID
21370210Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/21370210Abstract
Pre-eclampsia (P-EC) is a multisystem disorder exclusive to pregnancy. It complicates ~2 to 8% of all pregnancies and remains a major cause of maternal mortality. P-EC is characterized by a profound hypercoagulable state. The delicate hemostatic balance that must be maintained in the uteroplacental circulation during pregnancy makes this system vulnerable to perturbation. An abnormal hemostatic pattern occurs within the uteroplacental circulation in P-EC compared with normal pregnancy. Much recent research has focused on the epidemiological link between inherited thrombophilia and P-EC. The data suggest a weak statistical association, indicating an improbable primary role in the pathogenesis. Without clear evidence, low molecular weight heparins have been widely used to reduce recurrence of P-EC in thrombophilia-positive women. This practice now should be reviewed. Future research needs to focus on improving our basic scientific understanding of the role of the hemostatic system in human placentation.Item Type
ArticleLanguage
enISSN
1098-9064ae974a485f413a2113503eed53cd6c53
10.1055/s-0030-1270336
Scopus Count
Collections
Related articles
- Pre-eclampsia and inherited thrombophilia: a reappraisal.
- Authors: Rath W
- Issue date: 2011 Mar
- [Thrombophilia, preeclampsia and other pregnancy complications].
- Authors: Vucić N, Frleta M, Petrović D, Ostojić V
- Issue date: 2009 Oct
- Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
- Authors: Kalk JJ, Huisjes AJ, de Groot CJ, van Beek E, van Pampus MG, Spaanderman ME, van Eyck J, Oei SG, Bezemer PD, de Vries JI
- Issue date: 2004 Mar
- Tissue factor dependent pathway and the diagnosis of pre-eclampsia.
- Authors: Lwaleed BA, Dusse L, Cooper AJ
- Issue date: 2011 Mar
- Thrombophilia and pre-eclampsia.
- Authors: de Maat MP, de Groot CJ
- Issue date: 2011 Mar